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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).SUMMARY
Lymphatic vessels arise during development through
sprouting of precursor cells from veins, which is
regulated by known signaling and transcriptional
mechanisms. The ongoing elaboration of vessels to
form a network is less well understood. This involves
cell polarization, coordinated migration, adhesion,
mixing, regression, and shape rearrangements. We
identified a zebrafish mutant, lymphatic and cardiac
defects 1 (lyc1), with reduced lymphatic vessel devel-
opment. A mutation in polycystic kidney disease 1a
was responsible for the phenotype. PKD1 is the
most frequently mutated gene in autosomal domi-
nant polycystic kidney disease (ADPKD). Initial
lymphatic precursor sprouting is normal in lyc1
mutants, but ongoing migration fails. Loss of Pkd1
in mice has no effect on precursor sprouting but
leads to failed morphogenesis of the subcutaneous
lymphatic network. Individual lymphatic endothelial
cells display defective polarity, elongation, and
adherens junctions. This work identifies a highly
selective and unexpected role for Pkd1 in lymphatic
vessel morphogenesis during development.
INTRODUCTION
The lymphatic vasculature forms in the embryo as a result of
specification of lymphatic endothelial cell (LEC) fate, followed
by coordinated sprouting, morphogenesis, and network elabo-
ration. LEC fate is specified through key transcription factors,
which act in embryonic veins (Franc¸ois et al., 2008; Srinivasan
et al., 2010; Wigle and Oliver, 1999). LEC precursors subse-
quently sprout from veins and migrate through the embryo
(reviewed in Koltowska et al., 2013). This process is under the
control of VEGFC/VEGFR3 signaling (Karkkainen et al., 2004)and its modulators (reviewed in Koltowska et al., 2013). In
mouse, lymphatic precursors form lymph sacs in the anterior
of the embryo (Franc¸ois et al., 2012; Yang et al., 2012), which
likely remodel into major lymphatic vessels (Ha¨gerling et al.,
2013). Superficial LECs (sLECs) migrate dorsally as loosely
attached individual cells to form the subcutaneous lymphatic
network (Ha¨gerling et al., 2013). Although several guidance mol-
ecules, cellular interactions, and extrinsic forces pattern embry-
onic lymphangiogenesis (reviewed in Koltowska et al., 2013),
much remains to be understood about the cellular mechanisms
that regulate LEC polarization, adhesion, outgrowth, remodeling,
and morphogenesis.
In zebrafish, there are strong parallels with mammals in the
processes that regulate lymphatic vascular development (Hogan
et al., 2009b; Ku¨chler et al., 2006; Yaniv et al., 2006). We have
used forward genetic screens to identify zebrafish mutants that
lack lymphatic vessels. Here, one zebrafish mutant uncovers a
surprising role for the ADPKD gene Pkd1 in lymphatic vascular
development. We show that this function of Pkd1 is conserved
and cell autonomous in endothelial knockout mice. Our findings
suggest a uniquely staged role for PKD1 in the regulation of
lymphatic vascular morphogenesis.
RESULTS
lyc1 Mutants Fail to Form a Lymphatic Vasculature
We identified a zebrafish mutant dubbed lymphatic and cardiac
defects 1 (lyc1). lyc1mutants exhibited a reduction or loss of the
main axial lymphatic vessel, the thoracic duct (TD) at 4 days post-
fertilization (dpf) as well as mild cardiac edema, while retaining
blood circulation (Figures 1A–1D and 1I). By 5 dpf, mutant blood
flow was reduced and cardiac edema increased in severity (Fig-
ure S1; data not shown). To determine the origins of the pheno-
type,weexaminedgeneexpression for arteriovenousgenes, lym-
phangiogenesis regulators (includingchemokinesand receptors),
and flow-induced pathways at 32 hr postfertilization (hpf), during
the initiation of lymphatic development. These markers were un-
changed in lyc1 embryos (Figure S1). In the zebrafish, precursorCell Reports 7, 623–633, May 8, 2014 ª2014 The Authors 623
Figure 1. lyc1 Mutants Display Reduced Lymphatic Development
(A and B) Overall morphology of wild-type siblings (A) and lyc1 mutants (B) at 4 dpf.
(C and D) The vasculature Tg(fli1a:EGFPy1; flt1:tomatohu5333Tg) of (C) wild-type (WT) (arrowheads indicate thoracic duct) and (D) lyc1 mutants at 4 dpf (asterisks
indicate absence of thoracic duct).
(E and G) The vasculature Tg(fli1a:EGFP y1; flt1:tomatohu5333Tg) in wild-type sibling (E) and mutant embryos (G) at 56 hpf (arrows indicate lymphatic precursors
known as parachordal lymphangioblasts, PLs).
(F and H) flt1:tomatohu5333Tg expression marks the arterial ECs, a loss of signal (brackets) indicating venous intersegmental vessels (vISVs).
(I–K) Quantification of (I) thoracic duct extent across ten somites (WT n = 40, lyc1 n = 17), (J) parachordal lymphangioblasts (WT n = 78, lyc1 n = 17), and (K) venous
sprouts (WT n = 40, lyc1 n = 15). DA, dorsal aorta; PCV, posterior cardinal vein.
Error bars indicate SEM. See also Figures S1 and S2.
624 Cell Reports 7, 623–633, May 8, 2014 ª2014 The Authors
Figure 2. lyc1 Is a pkd1a Mutant
(A) Overview of positional cloning of lyc1. Individual recombinant embryos (labeled in red left [from 776 embryos analyzed], labeled in blue right [from 314 embryos
analyzed]) identify flanking polymorphic markers and limit the critical interval to a region containing partial sequences for pkd1a and tsc2.
(B) Sequence chromatograms showing the wild-type (upper) and pkd1a mutant (R3607X, lower) sequences.
(C) Overall morphology of 5 dpf WT, lyc1, MO-pkd1b, lyc1/MO-pkd1b, and MO-pkd2 embryos. The injection of MO-pkd1b into lyc1 mutants recapitulates the
published MO-pkd1a/1b double loss-of-function phenotype (Mangos et al., 2010).
(D) Expression pattern of pkd1a by in situ hybridization in the trunk of wild-type zebrafish at 24 hpf and 32 hpf.
(E) Quantitative RT-PCR for markers enriched in venous endothelial cells (VECs); kdrl, cdh5, LECs; prox1a, nfatc1, nrp2a; and both flt4 and lyve1 demonstrated
the purity of FACS-isolated populations at 5 dpf.
(F) Quantitative RT-PCR for pkd1a, pkd1b, and pkd2 transcripts in 3, 5, and 7 dpf VEC and LEC populations.
(G–I) The vasculature of 5 dpf WT, lyc1/MO-pkd1b and MO-pkd2 embryos (5 and 7.5 ng MO, respectively); asterisk indicates absence of thoracic duct in
Tg(fli1a:EGFP y1; kdrl:egfps843) embryos.
Error bars indicate SEM. See also Figures S3 and S4.LECs emerge from the posterior cardinal vein (PCV) during
secondary angiogenesis and migrate dorsally to the horizontal
myoseptum to form parachordal lymphangioblasts (PLs).
Concomitantly, venous sprouts form intersegmental veins
(vISVs). Strikingly, the numbers of vISVs and PLs were normal in
lyc1mutants (Figures 1E–1H, 1J, and 1K).
This phenotype differs from described mutants for vegfc,
vegfr3, or ccbe1 (Hogan et al., 2009a, 2009b; Le Guen et al.,
2014; Villefranc et al., 2013), which lack all venous sprouting.
Time-lapse imaging showed that the lymphatic defect resulted
from a block in themigration of PLs out of the horizontal myosep-
tum (Movies S1 and S2). Quantitative analysis of cell behavior
spanning this period of altered migration revealed that mutant
precursor LECs remain mobile but show altered exploratory
behavior and filopodial extension dynamics, consistent with
impaired directional migration (Movies S3 and S4; Figure S2).
A Loss-of-Function Mutation in pkd1a Is Responsible for
the lyc1 Phenotype
Meiotic mapping (see the Experimental Procedures) was used to
identify a region of chromosome 1 containing the lyc1 locus. The
critical interval (Figure 2A) contained two genes, tuberous
sclerosis 2 (tsc2) and polycystic kidney disease Ia (pkd1a). In
the zebrafish genome, pkd1 (encoding Polycystin1) is presentas duplicate genes, with pkd1a coding for a conserved 4281
amino acid protein. Sequencing revealed a mutation in pkd1a,
introducing a premature stop codon (R3607X) (Figure 2B). This
mutation was predicted to result in the failed translation of six
of the 11 transmembrane domains and essential C-terminal
cytoplasmic tail of the protein.
In humans,PKD1 and PKD2 (encoding POLYCYSTIN2) are the
most commonly mutated genes in ADPKD (for review, see
Chapin and Caplan, 2010; Zhou, 2009). PKD1 haploinsufficiency
and loss of function have also been frequently associated
with cardiovascular complications (reviewed in Rossetti and
Harris, 2013). In mammals, POLYCYSTIN1 protein localizes to
primary cilia, apical membranes, adherens, and desmosomal
junctions. It can act as a mechanosensory signaling protein,
transducing extracellular signals through its cytoplasmic C-ter-
minal domain (reviewed in Zhou, 2009). POLYCYSTIN1 binds
to POLYCYSTIN2 (a calcium pump) at the membrane to regulate
Ca2+ influx and signaling but also binds to E-cadherin, b-catenin,
and components/effectors of the planar cell polarity pathway
(Castelli et al., 2013; Lal et al., 2008; Roitbak et al., 2004).
Previous studies depleting Polycystin1 (a and b) in zebrafish
found that MO-pkd1a/b embryos exhibit a specific body curva-
ture phenotype (Mangos et al., 2010). We injected MO-pkd1b
into our pkd1a mutant embryos and robustly induced thisCell Reports 7, 623–633, May 8, 2014 ª2014 The Authors 625
Figure 3. Pkd1 Cell-Autonomously Regulates Subcutaneous Lymphatic Vascular Development in Mice
(A–C) Morphology of WT, Pkd1KO, and Pkd1iDECKO embryos at 14.5 dpc (arrowhead indicates edema).
(D–F) Lymph sacs (LS) in WT, Pkd1KO, and Pkd1iDECKO embryos stained with endomucin, LYVE1, and PROX1. JV, jugular vein. Scale bar represents 100 mm.
(G–I) Hematoxylin and eosin staining in WT, Pkd1KO, Pkd1iDECKO embryos at 14.5 dpc. Lymph sacs (LS) indicated.
(J and K) Subcutaneous lymphatics in Sox18:GFP-Cre-ERT2, Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J costained with NRP2 and PROX1 (n = 663/1,138 scored
LECs were tdTOMATO positive (58.2%), from n = 2 embryos, 13.5 dpc).
(L–N) Subcutaneous lymphatic vasculature inWT, Pkd1KO, and Pkd1DECKOmutants at 14.5 dpc. Dashed line indicated the dorsal midline of the embryo. Scale bar
represents 400 mm.
(O–Q) Representative subcutaneous lymphatic sprout in WT, Pkd1KO, and Pkd1iDECKO mutants at 14.5 dpc.
(R and S) Quantification of branchpoints/area (2,0003 1,500 mm area on both sides of the midline) in (R) WT (n = 7 embryos) and Pkd1KO (n = 7 embryos) and (S)
WT (n = 8 embryos) and Pkd1iDECKO (n = 6 embryos) embryos at 14.5 dpc.
(legend continued on next page)
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phenotype, confirming that the lyc1 mutation is a loss-of-func-
tion allele (Figures 2C and S3). Pkd1 and Pkd2 can modulate
extracellular matrix (ECM) formation (Mangos et al., 2010).
Importantly, even the most phenotypically penetrant pkd1a
mutants for lymphangiogenesis do not display the body curva-
ture associated with altered ECM.We examined several markers
and knockdown scenarios but found no evidence for increased
ECM or a role of altered matrix in the lyc1 lymphatic phenotype
(Figure S4).
pkd1a Is Expressed in Migrating LECs and Loss of
Function in the ADPKD Complex Mimics lyc1 Defects
We found that pkd1a expression was ubiquitous in the 24 hpf
embryo but was enriched in the trunk during secondary angio-
genesis at 32 hpf (Figure 2D). We saw no evidence for
nonsense-mediated decay in mutants using in situ hybridization
at 32 hpf (n = 130 embryos from a carrier incross analyzed; data
not shown). As in situ hybridization has proved insensitive in
LECs in older zebrafish (post 3 dpf), we isolated LECs using fluo-
rescence-activated cell sorting (FACS). Taking advantage of a
new transgenic line Tg(lyve1:DsRed2)nz101 (Okuda et al., 2012)
labeling embryonic veins and lymphatic vessels, crossed onto
the Tg(kdrl:egfp)s843 line (restricted to blood vessels; Jin et al.,
2005), we isolated LECs and venous ECs (VECs). We performed
quantitative PCR (qPCR) for knownmarkers, validating the spec-
ificity of cell populations (Figures 2E and S3). Consistent with the
timing of the lyc1 phenotype, pkd1a and pkd2were expressed in
VECs and LECs, with pkd1a in both populations at 3 dpf but
reduced in LECs at 5 dpf. pkd1b was expressed at low, almost
undetectable levels at all stages (Figures 2F and S3).
In endothelial cells, Polycystin1 can regulate calcium signaling
through Polycystin2 activity (Chapin and Caplan, 2010; Nauli
et al., 2003). To investigate this potential mechanism, we
knocked down Pkd2. Embryos depleted for Pkd2 exhibited a
phenotype similar to that of lyc1/MO-pkd1b embryos and
reduced TD extent (Figures 2G–2I and S3). We next treated
embryos with previously validated Ca2+ signaling antagonist
and agonists (North et al., 2009). These treatments generated
phenotypes highly reminiscent of the lyc1 phenotype (Figure S3).
Cacna1s, an L-type calcium channel targeted by the antagonist
Nifedipine, was expressed in ECs (Figure S3). Taken together,
these observations are consistent with Pkd1 functioning in the
canonical ADPKD complex.
Pkd1 Cell-Autonomously Regulates Development of the
Subcutaneous Lymphatic Vascular Network in Mice
Although most previous studies in mammalian models focus on
the role of Pkd1 in epithelia, Pkd1-null mice have been shown to
exhibit cardiovascular, skeletal, and renal defects (Boulter et al.,
2001; Kim et al., 2000; Piontek et al., 2004). Embryos devoid of
Pkd1 die after 15.5 days post coitum (dpc) displaying severe(T) Quantification of the average width of lymphatic vessels (mm) across the whol
embryos) embryos. The average is shown of n = 773, n = 354, and n = 250 measu
midline at 14.5 dpc.
(U) Quantification of nuclei/100 mm of vessel in WT (n = 12 embryos), Pkd1KO (n =
vessels counted per embryo) at 14.5 dpc.
Error bars indicate SEM. See also Figures S5 and S6.hemorrhaging and subcutaneous edema (Kim et al., 2000;
Muto et al., 2002), but a role for this gene in lymphangiogenesis
has yet to be reported.
We generated Pkd1 knockout embryos and examined their
overall morphology. We observed the previously described sub-
cutaneous edema, but not hemorrhaging (Figures 3A–3C).
Embryonic lymph sacs were present but were blood filled in
Pkd1 KO embryos (Figures 3D–3I). This phenotype suggests
that lymphatics in this mutant would not sustain fluid drainage
and may explain the subcutaneous edema. Interestingly, we
did not find any defect in lymphovenous valves at 14.5 dpc (Fig-
ure S5) perhaps suggesting that blood enters the mutant lymph
sacs early during morphogenesis, before valve maturation
(Franc¸ois et al., 2012). We next examined the developing subcu-
taneous lymphatic vasculature in dorsal embryonic skin, a useful
system to quantify lymphatic vascular phenotypes (James et al.,
2013; Kartopawiro et al., 2014). We found that Pkd1 KO embryos
exhibit defects in the morphogenesis of the lymphatic network,
with increased width of sprouting vessels, increased cell number
per vessel, and a significant reduction in network branching (Fig-
ures 3L, 3M, 3R, 3T, and 3U).
Previous studies reported that Tie2:Cre-mediated deletion of
Pkd1 did not lead to vascular abnormalities, and these knockout
mice did not display the edema observed in full knockout ani-
mals (Garcia-Gonzalez et al., 2010; Hassane et al., 2011). This
implies that the phenotypes that we observed may not reflect
endothelial autonomous function. To investigate this further,
we crossed the Tie2:Cre strain into a ROSA26r-LacZ back-
ground and examined Cre activity. Although active in blood ves-
sels, we could not detect activity throughout subcutaneous
lymphatic vessels (Figure S6). Hence, previous work would
not have uncovered function in these vessels. We generated
Tie2:Cre-mediated knockout embryos for Pkd1 and found no
subcutaneous lymphatic phenotype (Figure S5). Therefore, we
utilized Sox18:GFP-Cre-ErT2(GCE) as an additional endothelial
CRE strain (Kartopawiro et al., 2014). We validated the use of
Sox18:GCE on a Rosa26r-LacZ background, which demon-
strated activity throughout the vasculature (Figure S6). We also
used an inducible tdTomato reporter to quantify activity in sub-
cutaneous lymphatics by costaining with LEC markers NRP2
and PROX1. We found that induced Sox18:GCE was active in
58%of sprouting subcutaneous LECs at 13.5 dpc and frequently
in clonal regions spanning whole vessels (Figures 3J, 3K, and
S6H–S6Q; Movie S5).
We generated induced Pkd1 endothelial cell knockout
(iDECKO) embryos using this line. Pkd1iDECKO embryos dis-
played either mild or no subcutaneous edema at 14.5 dpc (Fig-
ure 3C), with lymph sacs present but not containing blood
(Figures 3I and 3F). In the subcutaneous lymphatic vasculature,
Pkd1iDECKO embryos displayed similar dramatic defects to germ-
line KO animals, if marginally milder on quantification (Figurese skin in WT (n = 15 embryos), Pkd1KO (n = 7 embryos), and Pkd1iDECKO (n = 6
rements, respectively, across leading lymphatic vessels from both sides of the
3 embryos), and Pkd1iDECKO (n = 6 embryos) (n = 5 representative leading edge
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3N, 3Q, 3T, and 3U).We examined the blood vasculature of Pkd1
KO embryos. Although we saw defects in Pkd1KO embryos,
these were at the dorsal midline associated with edema and
considered secondary to altered tissue architecture (Figure S5).
In contrast, Pkd1iDECKO embryos displayed normal blood vascu-
lature, including normal vessel width and branching (Figure S5).
Interestingly, Pkd1iDECKO embryos did not show reduced LEC
migration toward the midline (Figure 3N). This would be ex-
pected for mutants in known pathways such as VEGFC/
VEGFR3.
PKD1 Regulates Sprouting and Cell-Cell Junctions
In Vitro in Human LECs
Next, we examined the sprouting of human LECs in vitro in
response to VEGFC using a spheroid outgrowth assay. Small
interfering RNA (siRNA)-mediated knockdown of PKD1 in LECs
resulted in a reduced number of cells within individual spheroid
sprouts, with extensions exhibiting reduced length and abnormal
morphology (Figures 4A–4H; Figure S7). The efficacy of knock-
down with the siRNA mix was validated by qPCR, and the spec-
ificity was verified with an independent small hairpin RNA
(shRNA) knockdown (Figure S7). We examined the phenotype
of LECs in cultured monolayers and observed a rapid change
in morphology following PKD1 knockdown (Figures 4I–4P).
Stress fibers were disorganized in these cells (Figures 4I and
4M), and analysis of cell junctions revealed reduced VE-cadherin
and b-catenin and disorganized junctions following knockdown
(Figures 4J, 4K, 4N, and 4O). ZO-1 localization at tight junctions
was relatively unaffected in these assays, despite altered cell
morphology, suggesting a level of selectivity to adherens junc-
tions (Figures 4L and 4P). The levels of VE-cadherin were not
altered by western blot although b-catenin showed amild reduc-
tion (Figure S7), probably indicative of destabilized junctional
complexes.
Pkd1 Regulates Polarity and Cell-Cell Junctions during
Lymphatic Vessel Morphogenesis in Mice
Pkd1 has been implicated in the regulation of polarity in epithe-
lial cells and shown to regulate cellular convergent extension
and polarity during kidney tubule morphogenesis through
planar cell polarity (PCP) signaling (Castelli et al., 2013). PKD1
binds to PAR3 and aPKC as well as E-cadherin and b-catenin
therefore being associated with both polarity and junctional
components (Castelli et al., 2013; Lal et al., 2008; Roitbak
et al., 2004). Recently, the PCP pathway has been shown to
regulate junctional rearrangements in developing LECs, at least
during valve morphogenesis (Tatin et al., 2013).
We examined cell polarity in sprouting embryonic lymphatic
vessels. The Golgi apparatus orients toward the migration front
relative to the nucleus in many cell types including LECs (Fig-
ures 5A and 5C), serving as an ideal readout for polarity. We
quantified Golgi orientation in Pkd1 KO embryos and found it
to be significantly randomized in 14.5 dpc lymphatic vessels
compared with siblings (Figures 5A–5D and 5G). Furthermore,
this loss of polarity was associated with increased nucleus
sphericity in mutant vessels, a previously described proxy for
polarity and migratory behavior (Ha¨gerling et al., 2013)
(Figure 5H).628 Cell Reports 7, 623–633, May 8, 2014 ª2014 The AuthorsTo determine the earliest defect, we performed detailed
phenotypic analysis at 10.5 and 11.5 dpc. At 10.5 dpc, analysis
of PROX1 expression indicated that cell migration from the cardi-
nal vein and nuclear morphology was normal in mutants (Figures
5I, S6G, and S6H). However, at 11.5 dpc, although the blood
vasculature was grossly normal (Figure S5), mutant LECs at the
sprouting vessel front displayed increased nucleus sphericity
(decreased elipticity) compared with wild-type (Figure 5J). We
assessedGolgi orientation at these stages, but the direction of in-
dividual cell migration events was not regular, and the midline
cannot be used as a direction of migration until later in develop-
ment (data not shown). These early leading vessels also exhibited
increased width and numbers of nuclei relative to vessel length
similar to later Pkd1KO vessels (Figures S5I–S5J).
Finally, we investigated cell shape and the morphology of
junctions within lymphatic vessels. At 14.5 dpc, VE-cadherin
highlighted cell shape and showed that mutant cells failed to
elongate along the plane of migration toward the midline
compared with wild-type vessels (Figures 5K, 5L, 5O, 5P, and
5S). At the level of individual junctional morphology, both VE-
cadherin and b-catenin expression identified junctions that
displayed immature morphology with irregular intracellular pro-
trusions (arrowheads in Figures 5M, 5N, 5Q, and 5R). These
phenotypes were only seen in phenotypically mutant vessels
and not morphologically wild-type mutant vessels (data not
shown; phenotypic variability shown in Figure 3). Quantification
of the number of cells displaying immature junctions showed a
significant phenotype from as early as 12.5 dpc (Figures 5T–5V).
DISCUSSION
Our results, along with those of Outeda et al. (2014) published
in this issue of Cell Reports demonstrate the surprising finding
that Pkd1 is a regulator of lymphatic vessel development. In
zebrafish, at the cellular level, Pkd1 regulates LEC migration
out of the horizontal myoseptum but not initial sprouting from
veins that is regulated by ccbe1/vegfc/vegfr3 (Hogan et al.,
2009a, 2009b; Le Guen et al., 2014; Villefranc et al., 2013).
pkd1a is expressed in lymphatic precursor cells when they are
actively migrating, consistent with the earliest cellular defects
in the mutant.
It was important, given the highly studied nature of Pkd1, to ask
if this function was conserved in mammals. In knockout mice,
early specification and initial sprouting of LECs occurs normally.
However, defects are seen in the morphology of migrating LECs
at 11.5 dpc with morphological defects in the subcutaneous
lymphatic network prominent by 14.5 dpc. This uniquely timed
requirement is distinct fromphenotypes in knownpathways, sug-
gesting that Pkd1 may act by an uncharacterized mechanism in
LECs. Interestingly, the lymph sacs were blood filled in full
knockout but not in endothelial knockout mice, which displayed
only mild edema. This may be due to the staging of tamoxifen
treatment to knockout Pkd1 function from 9.5 or 11.5 dpc,
when lymph sacs are already establishing (Ha¨gerling et al.,
2013). The observation that the lymphatic phenotype was
reproduced by deletion with Sox18:GCE, active in LECs, but not
Tie2:Cre, which we observed acts in BECs, suggests that Pkd1
functions in the LECs themselves during vessel morphogenesis.
Figure 4. PKD1 Regulates Sprouting and Cell-Cell Junctions in LECs In Vitro
(A–F) Morphology of human LEC spheroids treated with control and PKD1 siRNA (50 nM) in BSA or VEGFC-supplemented conditions, stained with F-ACTIN
(green) and DAPI (blue). Scale bar represents 100 mm in (A), (B), (D), and (E) and 30 mm in (C) and (F).
(G and H) Quantification of number of sprouts (G) and number of nuclei per 100 mm of sprouts (H) in spheroids treated with control or PKD1 siRNA in BSA or
VEGFC-supplemented conditions.
(I–P) Morphology of human LECs treated with control or PKD1 siRNA (50 nM) VEGFC-supplemented conditions, stained with DAPI (blue) and F-ACTIN (green)
(I and M), b-catenin (pink) (J and N), VE-cadherin (red) (K and O), or ZO-1 (L and P).
Error bars indicate SEM. See also Figure S7.Given the diverse functions of the protein, several hypotheses
could explain the observed migration and morphogenesis de-
fects. PKD1 has been previously reported to function at the pri-
mary cilium in endothelial cells (Nauli et al., 2008). However, we
found lymphatic vessels developed normally in a ciliogenesis
mutant (ift88; Huang and Schier, 2009), we saw no evidence
for altered ciliogenesis in lyc1 mutants, and overexpression ofa Pkd1a-YFP fusion protein, driven by the pkd1a promoter
(BAC clone), did not lead to cilium enrichment (Figure S8).
Hence, we find no supportive evidence that Pkd1 in zebrafish
lymphatic development functions at the cilium. Because Pkd1
can also localize to adherens junctions, desmosomal junctions,
and intracellular organelles and has a number of binding part-
ners, it has the potential to act at diverse locations.Cell Reports 7, 623–633, May 8, 2014 ª2014 The Authors 629
Figure 5. Pkd1 Regulates Polarity and Cell-Cell Junctions in Mouse Embryonic Lymphatic Vessels
(A and B) Subcutaneous lymphatic vessels in skin of WT and Pkd1KO embryos at 14.5 dpc, stained with endomucin, NRP2, PROX1, and GOLPH4 (Golgi
apparatus), non-LEC GOLPH4 staining subtracted. Scale bar represents 20 mm.
(C and D) PROX1, GOLPH4 staining in WT and Pkd1KO lymphatic vessels. Arrowhead indicates Golgi; N, nucleus.
(legend continued on next page)
630 Cell Reports 7, 623–633, May 8, 2014 ª2014 The Authors
The earliest consequences of loss of function are changes
in cell morphology during morphogenesis, including altered
polarity and adhesion. Cell polarity and adhesion are intimately
associated and must be carefully regulated to control tissue
morphogenesis. It is hard to determine which defect is pri-
marily regulated by Pkd1. However, parallels can be drawn
with recent findings in kidney tubule development where Pkd1
regulates cellular convergent extension during tube formation
through the PCP pathway (Castelli et al., 2013). Although it will
take further work to delineate the pathways modulated by
Pkd1 in LECs, the finding of a crucial role in lymphatic vascular
development is unexpected and serves as a unique entry point
to understand lymphatic vascular morphogenesis.
EXPERIMENTAL PROCEDURES
Zebrafish Strains, Mapping, and Genotyping
Animal use conformed to guidelines of the animal ethics committee at the
University of Queensland. Zebrafish were maintained and screening per-
formed as previously described (Hogan et al., 2009a). Mapping and genotyp-
ing was performed as previously described (Hogan et al., 2009a). Primers are
given in Supplemental Experimental Procedures. The lyc1 mutant allele is
formally designated pkd1ahu5855. The Tg(flt1:YFP)hu4624Tg, Tg(kdrl:egfp)s843,
Tg(fli1a:EGFP)y1, Tg(6.5kdrl:mcherry)s916, Tg(0.8flt1:tdTomato)hu5333Tg,
and Tg(lyve1:DsRed2)nz101 lines were previously described (Bussmann et al.,
2010; Hogan et al., 2009b; Jin et al., 2005; Krueger et al., 2011; Lawson and
Weinstein, 2002; Okuda et al., 2012).
Mouse Strains
We generated Sox18:GFP-Cre-ErT2(GCE), B6.129S4-Pkd1tm2Ggg/J (Pkd1f/f);
Rosa26rLacZ (C57BL/6 background) mice by crossing Pkd1f/f mice to both
Rosa26rLacZ and Sox18:GFP-Cre-ErT2 mice and breeding resulting carriers.
We generated Tie2:Cre, Rosa26rLacZ (C57BL/6 background) mice by crossing
Tie2:Cre mice to Rosa26rLacZ and breeding resulting carriers. We generated
Sox18:GFP-Cre-ErT2(GCE), Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J by cross-
ing Sox18:GFP-Cre-ErT2 mice to Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J
homozygous mice. We generated Pkd1/ embryos by crossing Pkd1f/f mice
to B6.C-Tg(CMV-cre)1Cgn/J and incrossing resulting progeny in subsequent
generations. Genotyping primers are described in Supplemental Experimental
Procedures.(E and F) Lateral view of (E) WT (n = 3) and (F) Pkd1KO (n = 2) bisected embryo
morphology of migrating sLEC nuclei (analyzed above dashed line). Scale bar re
(G and H) Quantification of nucleus-Golgi vector angle (G) in WT (n = 3 embryos, n
sphericity (width to length ratio) in WT (n = 7, n = 299 nuclei) and Pkd1KO (n = 7,
(I and J) Quantification of nucleus sphericity in (I) dorsal-most iLECs in WT (n = 5
sLECs in WT (n = 3, n = 131 nucleus) and Pkd1KO (n = 2, n = 93 nucleus) embryo
(K and O) Representative subcutaneous lymphatic vessels in (K) WT and (O) Pkd
Scale bar represents 20 mm
(L and P) Representative cell shape schematics based on vessels shown in (K) a
sided arrows indicate elongation axes.
(M and Q) WT and Pkd1KO mutant cells at 14.5 dpc stained with PROX1 and V
represents 5 mm.
(N and R) WT and Pkd1KO mutant cells at 14.5 dpc stained with PROX1 and
represents 5 mm.
(S) Quantification of the angle of cell elongation relative to the direction of mig
embryos).
(T) Quantification of the average number of cells with abnormal junctions (stained
(n = 4 embryos, n = 16 vessels) at 14.5 dpc.
(U) Quantification of abnormal junctions (stained with b-catenin) in WT (n = 3 em
(V) Quantification of the average number of cells with abnormal junctions (stained
(n = 3 embryos, n = 7 vessels) at 12.5 dpc.
iLECS, initial LECs; PLLV, peripheral longitudinal lymphatic vessel; sLECS, supeImaging and Analysis
For confocal and spinning disk imaging, embryos were mounted as previously
described (Hogan et al., 2009b). Imaging was performed on a LSM Zeiss
510 NLO, META, or Zeiss 710 FCS confocal microscope with a 103, 203,
and 403 dry objective and 633 oil objective. Images were analyzed with the
Zen software, Biplane IMARIS, Photoshop, and ImageJ.
Morpholino Oligomers
Morpholino oligomers against pkd1a (morpholino oligomer [MO] ex8), pkd1b
(MO ex45), and pkd2 (MO ATG) were described in Mangos et al. (2010) and
were injected at 5, 7.5, or 10 ng/embryo as described (Hogan et al., 2008).
Quantitative Real-Time PCR
Procedures were performed in order to comply with MIQE guidelines (Bustin
et al., 2009) and are given in full in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
eight figures, one table, and five movies and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2014.03.063.
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